Search

Design Therapeutics Inc

Gesloten

12.46 3.06

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

12.08

Max

12.32

Belangrijke statistieken

By Trading Economics

Inkomsten

-1.6M

-18M

EPS

-0.29

Werknemers

54

EBITDA

534K

-17M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+70.36% upside

Dividenden

By Acuity

Volgende Winsten

5 aug 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-58M

742M

Vorige openingsprijs

9.4

Vorige sluitingsprijs

12.46

Design Therapeutics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

2 aug 2026, 23:51 UTC

Cautious Optimism Surrounds Upcoming South Korea Manufacturing PMI Release Amid Mixed Economic Signals and Regional Trends

2 aug 2026, 23:51 UTC

Japan's Upcoming Current Account Release on August 9, 2026, Expected to Reflect Export-Import Balance Amidst Cautiously Optimistic Market Sentiment.

2 aug 2026, 23:51 UTC

Correlated Moves
Macro News

Bitcoin is trading higher, influenced by rising crude oil prices and positive tech stock performance. Ethereum's increase also supports Bitcoin's upward movement today.

2 aug 2026, 23:31 UTC

Bitcoin and Ethereum rise amid market volatility and geopolitical tensions, as investors brace for potential Fed rate hikes and key economic data releases.

2 aug 2026, 23:31 UTC

Bitcoin and Ethereum rise amid market volatility, while momentum trading strategies face significant drawdowns as the Fed's steady interest rates and geopolitical tensions influence investor sentiment.

2 aug 2026, 23:31 UTC

Bitcoin and Ethereum rise amid geopolitical tensions and potential U.S. rate hikes, as investors brace for key labor market data.

2 aug 2026, 23:31 UTC

Bitcoin and Ethereum rise amid declining momentum trading strategies, while geopolitical tensions and inflation concerns heighten expectations for a potential Federal Reserve interest rate hike.

2 aug 2026, 23:21 UTC

Social Media
Correlated Moves
Macro News

Geopolitical tensions and rising fuel prices are driving demand for gold. Gold has gained modestly since Friday, with silver also rising today.

2 aug 2026, 23:02 UTC

Correlated Moves

AUD/CAD is higher in after-market trading, reflecting a modest gain since Friday's close and correlating with a rise in AUD/USD.

2 aug 2026, 23:01 UTC

Correlated Moves

Gold/JPY is advancing during Sunday’s session, supported by rising gold prices. The pair remains below its 20-day moving average amid ongoing market volatility.

2 aug 2026, 23:01 UTC

Correlated Moves
Macro News

EUR/USD rises in after-market trading, reflecting market reactions to potential U.S. monetary policy changes and concerns about a financial crisis linked to AI developments.

2 aug 2026, 23:01 UTC

Copper is trading higher during Sunday’s session, maintaining strength despite a slight pullback from earlier gains. It remains above its 20-day moving average.

2 aug 2026, 23:01 UTC

GBP/NOK is trading higher in after-market hours, reflecting a shift in trading dynamics despite recent market volatility and being near the lower end of its one-month range.

2 aug 2026, 23:01 UTC

Correlated Moves

Silver prices are advancing today, reflecting a broader upward movement in precious metals, despite earlier intraday volatility. Gold's increase may support silver's rise.

2 aug 2026, 23:01 UTC

Correlated Moves

Gold/NZD is higher today, recovering from an earlier low and reflecting a similar rise in gold prices since Friday's close.

2 aug 2026, 23:01 UTC

Correlated Moves

Silver/CHF is trading higher, recovering from earlier lows and reflecting a strong upward trajectory since Friday's close, in line with rising gold prices.

2 aug 2026, 23:01 UTC

Macro News

The Nikkei 225 Index is lower in after-market hours, continuing a decline linked to a weaker yen and potential interest rate hikes amid inflation concerns.

2 aug 2026, 23:01 UTC

Correlated Moves

Silver/GBP is trading higher, recovering from an earlier dip. The asset has increased notably since Friday's close, reflecting a strong correlation with gold.

2 aug 2026, 23:01 UTC

Correlated Moves

Gold/CAD is trading higher, rebounding from earlier losses amid rising silver prices. Broader market sentiment shows a decline in momentum trading strategies.

2 aug 2026, 23:01 UTC

Correlated Moves

The S&P 500 Index is trading higher, continuing a trend of three consecutive positive sessions, supported by gains in the Dow Jones Index.

2 aug 2026, 23:01 UTC

Correlated Moves

Silver/JPY is trading higher amid market volatility, reflecting a notable increase. The rise aligns with a gain in gold, indicating a strong correlation.

2 aug 2026, 23:01 UTC

Correlated Moves

Silver/SGD is trading higher, reflecting a broader rise in precious metals. Earlier, the asset pulled back but has since rebounded from session lows.

2 aug 2026, 23:01 UTC

Correlated Moves

Gold/AUD is rising today, supported by an increase in Gold (XAU/USD). The price remains near the lower end of its one-month trading range.

2 aug 2026, 23:01 UTC

Correlated Moves

Gold/CHF is advancing, reflecting gains in Gold (XAU/USD) and macroeconomic factors. Recent market volatility continues to influence investor risk sentiment.

2 aug 2026, 23:01 UTC

Correlated Moves

Gold/GBP is trading higher, recovering from an earlier dip amid increased Gold prices and shifts in investor sentiment during market volatility.

2 aug 2026, 23:01 UTC

Correlated Moves

Silver/NZD is trading higher, recovering from earlier fluctuations, as gold prices rise. It remains about 1.03% below its 20-day moving average.

2 aug 2026, 23:01 UTC

Correlated Moves

Silver/HKD is trading higher today, supported by a rise in gold prices. Earlier, it experienced notable volatility but has since recovered above Friday's close.

2 aug 2026, 23:01 UTC

Macro News

The US 5Y Treasury Bond Index is higher, recovering from an early dip amid Federal Reserve discussions on interest rate hikes and inflation concerns.

2 aug 2026, 23:01 UTC

Correlated Moves

Silver Ounce vs Euro shows notable gains today, driven by rising gold prices. Earlier, XAG/EUR pulled back from a session high but remains elevated.

2 aug 2026, 23:01 UTC

Correlated Moves

Gold/HKD is higher today, reflecting a modest gain since Friday's close amid broader market volatility and heightened investor anxiety.

Peer Vergelijking

Prijswijziging

Design Therapeutics Inc Prognose

Koersdoel

By TipRanks

70.36% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 20.75 USD  70.36%

Hoogste 22 USD

Laagste 20 USD

Gebaseerd op 5 Wall Street-analisten die 12-maands prijsdoelen bieden voor Design Therapeutics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

5 ratings

5

Buy

0

Hold

0

Sell

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Design Therapeutics Inc

Design Therapeutics, Inc. a biopharmaceutical company, researches, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States. The company utilizes its GeneTAC platform to design and develop therapeutic candidates for inherited diseases caused by nucleotide repeat expansion. Its lead product candidates for potentially disease-modifying treatment comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function that brings to neurological, cardiac, and metabolic dysfunction; Myotonic Dystrophy Type-1, a dominantly-inherited, monogenic progressive neuromuscular disease affecting skeletal muscle, heart, brain, and other organs; Fuchs Endothelial Corneal Dystrophy, a genetic eye disease characterized by bilateral degeneration of corneal endothelial cells and progressive loss of vision; and Huntington's Disease, a dominantly inherited, monogenic neurodegenerative disease characterized by movement, cognitive, and psychiatric disorders. Design Therapeutics, Inc. was incorporated in 2017 and is headquartered in Carlsbad, California.
help-icon Live chat